- Home
- ASYS vs PLRX Comparison
ASYS vs PLRX Comparison
Compare ASYS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- PLRX
- Stock Information
- Founded
- ASYS 1981
- PLRX 2015
- Country
- ASYS United States
- PLRX United States
- Employees
- ASYS N/A
- PLRX N/A
- Industry
- ASYS Industrial Machinery/Components
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- PLRX Health Care
- Exchange
- ASYS Nasdaq
- PLRX Nasdaq
- Market Cap
- ASYS 83.0M
- PLRX 93.3M
- IPO Year
- ASYS N/A
- PLRX 2020
- Fundamental
- Price
- ASYS $9.17
- PLRX $1.52
- Analyst Decision
- ASYS
- PLRX Hold
- Analyst Count
- ASYS 0
- PLRX 10
- Target Price
- ASYS N/A
- PLRX $3.93
- AVG Volume (30 Days)
- ASYS 476.5K
- PLRX 420.6K
- Earning Date
- ASYS 08-06-2025
- PLRX 11-06-2025
- Dividend Yield
- ASYS N/A
- PLRX N/A
- EPS Growth
- ASYS N/A
- PLRX N/A
- EPS
- ASYS N/A
- PLRX N/A
- Revenue
- ASYS $83,634,000.00
- PLRX N/A
- Revenue This Year
- ASYS N/A
- PLRX N/A
- Revenue Next Year
- ASYS $12.93
- PLRX N/A
- P/E Ratio
- ASYS N/A
- PLRX N/A
- Revenue Growth
- ASYS N/A
- PLRX N/A
- 52 Week Low
- ASYS $3.20
- PLRX $1.10
- 52 Week High
- ASYS $10.25
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- ASYS 59.22
- PLRX 49.18
- Support Level
- ASYS $8.28
- PLRX $1.42
- Resistance Level
- ASYS $10.09
- PLRX $1.55
- Average True Range (ATR)
- ASYS 0.79
- PLRX 0.08
- MACD
- ASYS -0.13
- PLRX -0.00
- Stochastic Oscillator
- ASYS 45.18
- PLRX 62.50
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.